Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30%
01:10pm, Thursday, 28'th Jul 2022
Teva posted second-quarter results that exceeded market expectations. Teva's outlook looks bright.
PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday
09:24am, Thursday, 28'th Jul 2022 Benzinga
U.S. stocks closed sharply higher on Wednesday, with the Dow Jones jumping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Pzena Investment Management
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
08:22am, Thursday, 28'th Jul 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Ch
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
06:05pm, Wednesday, 27'th Jul 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday.
The Dow traded up 0.49% to 31,915.65 while the NASDAQ rose 2.83% to 11,889.90. The S&
Teva Pharmaceutical Industries (TEVA) Q2 2022 Earnings Call Transcript
06:00pm, Wednesday, 27'th Jul 2022 The Motley Fool
TEVA earnings call for the period ending June 30, 2022.
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
04:38pm, Wednesday, 27'th Jul 2022 Benzinga
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.
The Dow traded up 0.45% to 31,904.19 while the NASDAQ rose 2.77% to 11,883.01. Th
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
04:07pm, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Med
TEVA Beats on Q2 Earnings, to Settle Opioid Lawsuit for $4.3B
02:32pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
TEVA reports mixed Q2 results. It lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact. The company agrees to settle opioid lawsuits for as much as $4.2
Teva Pharmaceutical Industries Limited's (TEVA) CEO Kare Schultz on Q2 2022 Results - Earnings Call Transcript
12:17pm, Wednesday, 27'th Jul 2022
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q2 2022 Earnings Conference Call July 27, 2022 8:00 AM ET Company Participants Ran Meir – Senior Vice President, Head of Investor Relations Kare S
Why Teva Pharmaceutical Industries Stock Is On Fire Today
12:13pm, Wednesday, 27'th Jul 2022 The Motley Fool
The drugmaker's opioid litigation may soon be resolved.
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
12:13pm, Wednesday, 27'th Jul 2022
Yahoo Finance anchor Brad Smith reports the latest notable business headlines including pharmaceutical company Teva reaching an opioid settlement, Credit Suisse naming Ulrich Koerner as the company's
Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:29am, Wednesday, 27'th Jul 2022 Benzinga
Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a ri
Teva Pharmaceutical Soars After Inking More Than $4 Billion In Opioid Deals
11:29am, Wednesday, 27'th Jul 2022
Teva Pharma inked settlement deals worth upward of $4 billion for its role in the opioid crisis, and Teva stock skyrocketed on Wednesday. The post Teva Pharmaceutical Soars After Inking More Than $4 B
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
11:03am, Wednesday, 27'th Jul 2022
Source: JHVEPhoto / Shutterstock.com Teva Pharmaceuticals (NYSE: TEVA ) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits. According to rece
Pharma Stock Explodes After Massive Settlement, Earnings
10:55am, Wednesday, 27'th Jul 2022
Shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are exploding today, after the drugmaker agreed to pay up to $4.25 billion for its alleged role in the U.S. opioid crisis.
